Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | CNR2 | P34972 | 5/20 | 0.54 |
| ▸ | PLAU | P00749 | 2/20 | 0.48 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.48 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | F12 | P00748 | 1/20 | 0.48 |
| ▸ | NCF1 | P14598 | 1/20 | 0.48 |
| ▸ | NOS3 | P29474 | 1/20 | 0.48 |
| ▸ | NOS1 | P29475 | 1/20 | 0.48 |
| ▸ | NOS2 | P35228 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CFTR | P13569 | 1/20 | 0.47 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28134671 | 0.98 | RAB9A (0.55) | RAB9ACNR2PLAUNR4A1NR4A2 | |
| Ammonia Solution, Strong SCHEMBL28091481 | 0.98 | RAB9A (0.55) | RAB9ACNR2PLAUNR4A1NR4A2 | |
| Hydrochloric Acid SCHEMBL3294760 | 0.98 | RAB9A (0.55) | RAB9ACNR2PLAUNR4A1NR4A2 | |
| SCHEMBL22664584 | 0.98 | RAB9A (0.55) | RAB9ACNR2PLAUNR4A1NR4A2 | |
| SCHEMBL4279451 | 0.91 | RAB9A (0.50) | RAB9ACNR2PLAUNR4A1NR4A2 | |
| SCHEMBL7570493 | 0.91 | PLAU (0.50) | RAB9ACNR2PLAUNR4A1NR4A2 | |
| Hydrochloric Acid SCHEMBL4282133 | 0.90 | RAB9A (0.49) | RAB9ACNR2PLAUNR4A1NR4A2 | |
| 2-Picolinic Acid SCHEMBL9108057 | 0.88 | L3MBTL1 (0.62) | RAB9ACNR2LMNAMAPTTSHR | |
| SCHEMBL5682387 | 0.87 | RAB9A (0.50) | RAB9ACNR2NR4A1NR4A2NR4A3 | |
| SCHEMBL4404077 | 0.86 | CNR2 (0.64) | RAB9ACNR2PLAUCYP2A6F12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1968 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-12497636-B2 | Recombinant Saccharomyces cerevisiae cells for cannabinoid production | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-12-16 | — | — | US | claimed |
| CN-119859148-A | Spiroteine framework compound and preparation method and application thereof | 安徽农业大学 | 2025-04-22 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| WO-2024115546-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2024-06-06 | — | — | WO | claimed |
| CN-117986245-A | Detection reagent for metal alkoxide, preparation and application thereof | 北京瑞博奥医药科技有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-111295382-B | Bridged bicyclic compounds as farnesyl ester X receptor modulators | 百时美施贵宝公司 | 2024-02-02 | — | — | CN | claimed |
| CN-117050300-A | Polylysine-based polymer adjuvant material, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2023-11-14 | — | — | CN | claimed |
| CN-116444430-A | Off-on near infrared lead ion detection fluorescent probe YSQ and preparation method and application thereof | 江苏科技大学 | 2023-07-18 | — | — | CN | claimed |
| US-11697636-B2 | Substituted benzamides | HOFFMANN-LA ROCHE INC. (US) | 2023-07-11 | — | — | US | claimed |
| CN-1084174-A | The method for preparing Physostigmine carbamate derivative by Physostigmine | HOECHST ROUSSEL PHARMA (US) | 1994-03-23 | — | — | CN | claimed |
| CN-1077960-A | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORP (US) | 1993-11-03 | — | — | CN | claimed |
| WO-1993013789-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-07-22 | — | — | WO | claimed |
| EP-0527186-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | The Board of Trustees for the University of Illinois (US) | 1993-02-17 | — | — | EP | claimed |
| WO-1991016820-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1991-11-14 | — | — | WO | claimed |
| US-5021421-A | Psychotropic agents | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1991-06-04 | — | — | US | claimed |
| EP-0244167-B1 | IMPROVED PROCESS FOR PREPARING POLY (ARYL ETHERS) AND POLY (ARYL ETHER KETONES) | AMOCO CORPORATION (US) | 1990-04-04 | — | — | EP | claimed |
| US-4748227-A | Process for preparing poly(aryl ether)ketones using a sodium carbonate/organic acid salt catalyst | AMOCO CORPORATION (US) | 1988-05-31 | — | — | US | claimed |
| EP-0244167-A1 | Improved process for preparing poly (aryl ethers) and poly (aryl ether ketones) | AMOCO CORPORATION (US) | 1987-11-04 | — | — | EP | claimed |
| EP-0096157-A2 | Substituted acyl derivatives of 1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid | WARNER-LAMBERT COMPANY (US) | 1983-12-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11697636-B2 | Substituted benzamides | TAAR1, TAAR5, NPY1R | RAB9A 1592/4885CNR2 117/4885PLAU 4328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.